Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Prognostic factors in head-neck carcinomas].

A Weber1, A Tannapfel

  • 1Klinik für Hals-Nasen-Ohren-Heilkunde, plastische Operationen, Universitätsklinikum Leipzig, Liebigstrasse 18a, 04103 Leipzig.

HNO
|April 20, 2002
PubMed
Summary

Head and neck squamous cell carcinoma remains a deadly cancer. Current molecular markers lack clinical relevance for early detection, prognosis, and personalized treatment, necessitating better predictive parameters.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Chemotherapy for patients with circulating tumour DNA-positive, stage II colon cancer (CIRCULATE)-an AIO/ABCSG trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2026
Same author

Echovirus serotype 11 induced sepsis in a young female patient with multiple sclerosis treated with anti-CD20 monoclonal antibody ocrelizumab.

Infection·2025
Same author

Impact of primary tumor sidedness and sex on prognosis and anti-epidermal growth factor receptor antibody efficacy in BRAF-mutant metastatic colorectal cancer: a pooled analysis of AIO studies FIRE-1, CIOX, FIRE-3, XELAVIRI, and VOLFI.

ESMO open·2024
Same author

Postoperative Peritoneal Granulomatous Inflammation After the Application of Potato Starch-Based Anti-Adhesive Agent in Laparoscopic Endometriosis Surgery.

Facts, views & vision in ObGyn·2023
Same author

Perioperative or only adjuvant gemcitabine plus nab-paclitaxel for resectable pancreatic cancer (NEONAX)-a randomized phase II trial of the AIO pancreatic cancer group.

Annals of oncology : official journal of the European Society for Medical Oncology·2022
Same author

Zeitschrift fur Gastroenterologie·2022

Area of Science:

  • Oncology
  • Molecular Biology
  • Carcinogenesis

Context:

  • Head and neck squamous cell carcinoma (HNSCC) is a prevalent cancer with high mortality.
  • Despite advances, diagnostic and therapeutic outcomes for HNSCC have not significantly improved over two decades.

Purpose:

  • To review current understanding of HNSCC carcinogenesis.
  • To discuss prognostic parameters for HNSCC.
  • To highlight the need for improved clinical and molecular markers for personalized therapy.

Summary:

  • Carcinogenesis involves genetic instability, cell cycle dysregulation, apoptosis changes, and alterations in oncogenes and tumor suppressor genes.
  • Existing molecular markers are insufficient for early detection, prognosis, and individualized HNSCC treatment.
  • The UICC TNM staging system offers prognostic insights, but better predictive parameters are required.

Impact:

  • Identifies limitations of current molecular markers in HNSCC management.
  • Underscores the critical need for novel biomarkers to predict prognosis and guide personalized HNSCC therapy.
  • Informs future research directions for improving HNSCC patient outcomes.

Related Experiment Videos